Search hospitals > Minnesota > Minneapolis
CCOP - Metro-Minnesota
Claim this profileMinneapolis, Minnesota 55416
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
536 reported clinical trials
6 medical researchers
Summary
CCOP - Metro-Minnesota is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, Cancer, Prostate Cancer and other specialties. CCOP - Metro-Minnesota is involved with conducting 536 clinical trials across 415 conditions. There are 6 research doctors associated with this hospital, such as Daniel M. Anderson, Yan Ji, Arkadiusz Dudek, MD, and Joseph W. Leach.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage II
2Lung Cancer
Global LeaderStage IV
PD-L1 positive
KRAS positive
Top PIs
Daniel M. AndersonAbbott-Northwestern Hospital6 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
61 reported clinical trials
110 drugs studied
Yan JiRegions Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
32 reported clinical trials
78 drugs studied
Arkadiusz Dudek, MDRegions Cancer Care Center5 years of reported clinical research
Studies Lung Cancer
Studies Solid Tumors
14 reported clinical trials
23 drugs studied
Joseph W. LeachMetro Minnesota Community Oncology Research Consortium13 years of reported clinical research
Studies Fallopian Tube Cancer
Studies Ovarian Cancer
1 reported clinical trial
5 drugs studied
Clinical Trials running at CCOP - Metro-Minnesota
Esophageal cancer
Gastric cancer
Stomach Cancer
Gastroesophageal Junction Adenocarcinoma
Cancer
Lung Cancer
Colorectal Cancer
Lymphoma
Gastroesophageal Junction Cancer
Blood Cancers
Ramucirumab + Trifluridine/Tipiracil or Paclitaxel
for Gastric Cancer
This phase II trial studies the effect of the combination of ramucirumab and trifluridine/tipiracil or paclitaxel in treating patients with previously treated gastric or gastroesophageal junction cancer that has spread to other places in the body (advanced). Ramucirumab may damage tumor cells by targeting new blood vessel formation. Trifluridine/tipiracil is a chemotherapy pill and that may damage tumor cells by damaging their deoxyribonucleic acid (DNA). Paclitaxel may block cell growth by stopping cell division which may kill tumor cells. Giving ramucirumab and trifluridine/tipiracil will not be worse than ramucirumab and paclitaxel in treating gastric or gastroesophageal junction cancer.
Recruiting1 award Phase 21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CCOP - Metro-Minnesota?
CCOP - Metro-Minnesota is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, Cancer, Prostate Cancer and other specialties. CCOP - Metro-Minnesota is involved with conducting 536 clinical trials across 415 conditions. There are 6 research doctors associated with this hospital, such as Daniel M. Anderson, Yan Ji, Arkadiusz Dudek, MD, and Joseph W. Leach.
Where is CCOP - Metro-Minnesota located?
The CCOP at Metro-Minnesota hospital is conveniently situated at 3800 Park Nicollet Blvd, Minneapolis, MN 55416, just a 15-minute drive from downtown Minneapolis via I-394 W and MN-100 N.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries in Minnesota, contact the Minnesota Department of Human Services at 651-431-6500 for information on health care programs including Medicaid and MinnesotaCare. HealthPartners offers a Financial Assistance Program for eligible individuals; call 651-265-1999 or 877-655-2669 (toll-free) to apply. The MetroHealth System provides financial assistance based on the Federal Poverty Guidelines, available at 216-957-2325, Option 1, Monday - Friday, 8 a.m. to 5 p.m. M Health Fairview also offers financial assistance; contact them at 612-672-2000 for more information.
What insurance does CCOP - Metro-Minnesota accept?
CCOP - Metro-Minnesota accepts a wide range of insurance plans, including Original Medicare, Medicare Advantage Plans (with and without Drug Coverage), Medicare Health Plans with Supplemental Coverage (Medigap), and Accepted Commercial Plans. For details on specific commercial plans accepted, please contact the hospital directly or verify with your plan administrator for coverage confirmation at an Allina Health facility.
What awards or recognition has CCOP - Metro-Minnesota received?
The Metro-Minnesota Community Oncology Research Consortium (MMCORC), renowned for its extensive history in cancer research and care, collaborates with 25 hospitals and clinics in the Minneapolis-St. Paul area and surrounding suburbs. It boasts over 160 physician-researchers specializing in various oncology fields. Currently, MMCORC is conducting more than 100 open clinical trials targeting specific types of cancer.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.